


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:49:29Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12406311" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12406311</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>annmed</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Med</journal-id><journal-id journal-id-type="iso-abbrev">Ann Med</journal-id><journal-id journal-id-type="pmc-domain-id">3997</journal-id><journal-id journal-id-type="pmc-domain">annmed</journal-id><journal-title-group><journal-title>Annals of Medicine</journal-title></journal-title-group><issn pub-type="ppub">0785-3890</issn><issn pub-type="epub">1365-2060</issn><publisher><publisher-name>Taylor &amp; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12406311</article-id><article-id pub-id-type="pmcid-ver">PMC12406311.1</article-id><article-id pub-id-type="pmcaid">12406311</article-id><article-id pub-id-type="pmcaiid">12406311</article-id><article-id pub-id-type="pmid">40891865</article-id><article-id pub-id-type="doi">10.1080/07853890.2025.2552936</article-id><article-id pub-id-type="publisher-id">2552936</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of Record</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cardiology &amp; Cardiovascular Disorders</subject></subj-group></article-categories><title-group><article-title>Association between occurrence time of myocardial injury after noncardiac surgery and long-term functional capacity: a secondary analysis of a prospective study</article-title><alt-title alt-title-type="left-running-head">T.-Y. Tang et al.</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0004-9131-3623</contrib-id><name name-style="western"><surname>Tang</surname><given-names initials="TY">Tian-Ying</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><xref rid="AF0001" ref-type="aff">a</xref><xref rid="AUFN2" ref-type="author-notes">#</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9933-7249</contrib-id><name name-style="western"><surname>Liu</surname><given-names initials="JM">Jia-Ming</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><xref rid="AF0001" ref-type="aff">a</xref><xref rid="AUFN2" ref-type="author-notes">#</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2762-8012</contrib-id><name name-style="western"><surname>Liu</surname><given-names initials="HM">Hua-Min</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><xref rid="AF0001" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0002-5025-444X</contrib-id><name name-style="western"><surname>Zhang</surname><given-names initials="J">Jing</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="AF0001" ref-type="aff">a</xref><xref rid="AF0002" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0009-6610-5634</contrib-id><name name-style="western"><surname>Zhang</surname><given-names initials="F">Fu</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="AF0001" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5671-4999</contrib-id><name name-style="western"><surname>Zhao</surname><given-names initials="BC">Bing-Cheng</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="AF0001" ref-type="aff">a</xref><xref rid="AN0002" ref-type="corresp"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0221-366X</contrib-id><name name-style="western"><surname>Liu</surname><given-names initials="KX">Ke-Xuan</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="AF0001" ref-type="aff">a</xref><xref rid="AN0001" ref-type="corresp"/></contrib><contrib contrib-type="author"><collab>for the PREVENGE-CB Collaborators</collab></contrib><aff id="AF0001"><label>a</label><institution>Department of Anaesthesiology, Nanfang Hospital, Southern Medical University; The key Laboratory of Precision Anaesthesia &amp; perioperative Organ Protection</institution>, <city>Guangzhou</city>, <state>Guangdong</state>, <country>China</country></aff><aff id="AF0002"><label>b</label><institution>School of Nursing, Southern Medical University</institution>, <city>Guangzhou</city>, <country>China</country></aff></contrib-group><author-notes><fn id="AUFN1"><p>Supplemental data for this article can be accessed online at <ext-link xlink:href="10.1080/07853890.2025.2552936" ext-link-type="doi">https://doi.org/10.1080/07853890.2025.2552936</ext-link>.</p></fn><fn id="AUFN2"><label>#</label><p>Tian-Ying Tang and Jia-Ming Liu contributed equally to this study</p></fn><corresp id="AN0001">CONTACT Ke-Xuan Liu <email xlink:href="mailto:liukexuan705@163.com">liukexuan705@163.com</email><institution>Department of Anaesthesiology, Nanfang Hospital, Southern Medical University</institution>, <addr-line>No. 1838 Guangzhou Avenue North</addr-line>, <postal-code>510515</postal-code>, <city>Guangzhou, Guangdong</city>, <country>China</country></corresp><corresp id="AN0002">Bing-Cheng Zhao <email xlink:href="mailto:zhaobch@mail2.sysu.edu.cn">zhaobch@mail2.sysu.edu.cn</email><institution>Department of Anaesthesiology, Nanfang Hospital, Southern Medical University, The Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection</institution>, <city>Guangzhou, Guangdong</city><postal-code>510515</postal-code>, <country>China</country>.</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>2</day><month>9</month><year>2025</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2025</year></pub-date><volume>57</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">476479</issue-id><elocation-id>2552936</elocation-id><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 10:25:45.023"><day>04</day><month>09</month><year>2025</year></date></event><event event-type="received"><date><day>26</day><month>4</month><year>2025</year></date></event><event event-type="revised"><date><day>12</day><month>8</month><year>2025</year></date></event><event event-type="accepted"><date><day>20</day><month>8</month><year>2025</year></date></event><event event-type="tagger"><event-desc>KnowledgeWorks Global Ltd.</event-desc><date><day>2</day><month>9</month><year>2025</year></date></event><event event-type="build-issue-online"><event-desc>published online in a building issue</event-desc><date><day>2</day><month>9</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="IANN_57_2552936.pdf"/><self-uri content-type="pdf" xlink:href="IANN_57_2552936.pdf"/><abstract><title>Abstract</title><sec><title>Background</title><p>Myocardial injury after noncardiac surgery (MINS) is associated with poor prognosis. The effect of different occurrence time of MINS on long-term functional capacity remains unclear in population with high cardiovascular risk.</p></sec><sec><title>Patients and methods</title><p>This cohort study included adult patients with increased cardiovascular risk undergoing elective major noncardiac surgery from June 2019 to September 2021. Patients with MINS were stratified in two groups on the basis of the occurrence time of MINS: within 24&#8201; hour (h) or after 24&#8201;h. The primary endpoint was disability at 180&#8201;days after surgery, evaluated by World Health Organization Disability Assessment Schedule 2.0. Disability was defined as &#8805;25% or an increase of 8%. Multivariable logistic regression was adopted to explore the association between occurrence time of MINS and primary endpoint. Propensity score weighting, including inverse probability weighting and overlap weighting, and subgroup analysis were used to explore the relationship further.</p></sec><sec><title>Results</title><p>2469 participants were included, of which 178 (7.2%) participants developed MINS within 24&#8201;h and 83 (3.4%) after 24&#8201;h. A total of 378 (15.3%) participants developed disability at 180&#8201;days after surgery, with an unweighted odds ratio (OR) of 1.97 (95% confidence intervals [CIs]: 1.17&#8211;3.32) for patients who suffered MINS after 24&#8201;h and weighted OR of 2.25 (95%CIs: 1.10&#8211;4.63) and 2.11 (95%CIs: 1.23&#8211;3.63) by IPW and OW, respectively. Findings were conserved in the subgroup analysis.</p></sec><sec><title>Conclusion</title><p>MINS occurring after 24&#8201;h was associated with worsen long-term functional capacity after surgery, whereas MINS occurring within 24&#8201;h was not.</p></sec></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>Disability</kwd><kwd>long-term functional capacity</kwd><kwd>myocardial injury</kwd><kwd>noncardiac surgery</kwd><kwd>troponin T surveillance</kwd></kwd-group><support-group><funding-group><award-group><funding-source><institution-wrap><institution>National Key Research and Development Program of China</institution><institution-id institution-id-type="open-funder-registry">10.13039/501100012166</institution-id></institution-wrap></funding-source><award-id>2023YFC2506900</award-id></award-group><funding-statement>This study was funded by National Key Research and Development Program of China (Beijing, China; 2023YFC2506900).</funding-statement></funding-group></support-group><counts><fig-count count="2"/><table-count count="4"/><page-count count="10"/><word-count count="5120"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" disp-level="1" id="S0001"><title>Introduction</title><p>Over 230 million noncardiac surgeries are performed in the world every year, and this number is still increasing [<xref rid="CIT0001" ref-type="bibr">1</xref>]. One in 6 patients experienced a complication, and 1 in 35 patients who suffered a complication subsequently died in the index hospitalisation; mortality was high (7.5%) within 1&#8201;year after surgery [<xref rid="CIT0002" ref-type="bibr">2</xref>]. Upon discharge, patients with or without complications pay more attention to returning to their preoperative lifestyle or functional capacity rather than traditional research endpoints, such as mortality and morbidity, which clinicians understandably focus on [<xref rid="CIT0003" ref-type="bibr">3</xref>,<xref rid="CIT0004" ref-type="bibr">4</xref>]. Postoperative complications evaluation during hospitalisation and functional capacity follow-up after discharge are important aspects of postoperative recovery, but consideration of the effect of postoperative complications on overall functional capacity is inadequate.</p><p>Myocardial injury after noncardiac surgery (MINS), a silent postoperative complication characterised with troponin elevation and absence of ischaemic features, was independently associated with increased 30-day mortality [<xref rid="CIT0005" ref-type="bibr">5</xref>]. Therefore, guidelines recommend single troponin measurement before surgery and a series 48&#8211;72&#8201;h postoperatively for high-risk population [<xref rid="CIT0006" ref-type="bibr">6&#8211;8</xref>]. For patients with mild preoperative troponin elevations, higher troponin level was associated with higher 30-day mortality after surgery, and longer time to surgery appeared to reduce this risk [<xref rid="CIT0009" ref-type="bibr">9</xref>]. After surgery, elevated troponin within 24&#8201;h was associated with the development of noncardiac organ dysfunction during hospitalisation [<xref rid="CIT0010" ref-type="bibr">10</xref>]; however, it is unclear that whether the prognosis improve or not along with time after surgery. Hence, this study focuses on the relationship between the occurrence time of MINS and long-term functional capacity.</p></sec><sec disp-level="1" id="S0002"><title>Patients and methods</title><sec disp-level="2" id="S0002-S2001"><title>Study design and population</title><p>The research was based on the data collected from PREdiction of Vascular Events after major Noncardiac surGEry with preoperative Cardiac Biomarkers study (PREVENGE-CB), a prospective cohort which aimed to assess the ability of preoperative N-terminal pro-B-type natriuretic peptide and troponin T to predict postoperative adverse cardiovascular events. The study was approved by the Ethical Committee of Southern Medical University Nanfang Hospital (Guangzhou, China; No. NFEC-2019-083; approved on May 8, 2019) and registered at the Chinese Clinical Trial Registry (ChiCTR1900023779). The Strengthening the Reporting of Observational Studies in Epidemiology reporting guidelines for cohort studies was attached in <ext-link xlink:href="10.1080/07853890.2025.2552936" ext-link-type="doi">supplementary material (Supplementary Table S1</ext-link>). Briefly, we included patients aged &#8805;45&#8201;years who had at least one known cardiovascular diseases (coronary heart disease, chronic heart failure, stroke or peripheral vascular disease) or carried two or more risk factors for cardiovascular diseases from June 2019 to September 2021. Venous blood samples were collected at the time between recruitment and anaesthesia induction and on the morning of the first and second days after surgery to measure troponin T concentrations via the fifth-generation elecsys troponin T assay (Roche Diagnostics, China), with a 99th percentile URL of 14&#8201;ng/L for both men and women. Additional troponin T measurements were performed as needed during the hospitalisation. All the participants provided written informed consent. Participants without troponin T measurement before or after surgery, who missed telephone follow-up at 180&#8201;days postoperatively or died in the index hospitalisation were excluded from this analysis. Detailed inclusion and exclusion criteria have been indicated in our previous study [<xref rid="CIT0011" ref-type="bibr">11</xref>].</p></sec><sec disp-level="2" id="S0002-S2002"><title>Data collection and definition</title><p>Clinical data, including demographic characteristics, comorbidities, examinations, functional capacity, surgery information, type of anaesthesia and postoperative complications, were collected through interview or from electronic medical records. Cardiovascular comorbidities involve coronary heart disease, chronic heart failure, stroke, peripheral vascular disease, hypertension and atrial fibrillation. Postoperative cardiovascular complications include myocardial infarction, cardiac arrest, heart failure, stroke, new atrial fibrillation and pulmonary embolism. MINS is defined as a postoperative troponin T level ranging from 20&#8201;ng/L to less than 65&#8201;ng/L with an absolute change of at least 5&#8201;ng/L or a postoperative troponin T level of at least 65&#8201;ng/L ascribed to myocardial ischaemia, without ischaemic features, following the criterion of the Vascular Events in Noncardiac Surgery Patients Cohort Evaluation (VISION) study [<xref rid="CIT0005" ref-type="bibr">5</xref>]. Disability was evaluated through the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) face to face at 1&#8201;day before surgery and by telephone-based version at 180&#8201;days after surgery. The 12-item WHODAS 2.0 was recommended by the Standardised Endpoints in Perioperative Medicine-Core Outcome Measures in Perioperative and Anaesthetic Care (StEP-COMPAC) working group as functional capacity measurement, in which the validity and reliability of the telephone-based version in long-term outcome were assessed in diverse surgical cohort [<xref rid="CIT0012" ref-type="bibr">12&#8211;14</xref>]. For patients with a preoperative disability score of &lt;25%, disability is defined as a disability score &#8805;25% at follow-up. If the preoperative disability score is &#8805;25%, an increase of 8% after surgery denotes a disability [<xref rid="CIT0014" ref-type="bibr">14</xref>]. Death is maximal disability. Definitions or diagnosis criteria of comorbidities and postoperative complications are listed in <ext-link xlink:href="10.1080/07853890.2025.2552936" ext-link-type="doi">supplementary material</ext-link>.</p></sec><sec disp-level="2" id="S0002-S2003"><title>Statistical analysis</title><p>Continuous variables were described as mean (standard deviation) or median (interquartile range) and compared by Student&#8217;s <italic toggle="yes">t</italic> test or Mann&#8211;Whitney <italic toggle="yes">U</italic> test or Kruskal&#8211;Wallis <italic toggle="yes">H</italic> test or one-way analysis of variance, as appropriate. Categorical variables were presented as count (percentage) and compared via Pearson &#967;<sup>2</sup> test or corrected &#967;<sup>2</sup> test. Variance inflation factors (VIFs) were calculated to assess the multicollinearity of all variables in the model. Multivariable logistic regression analyses were performed to explore the association between occurrence time of MINS and disability at 180&#8201;days after surgery. Several models were applied: the first model only included the occurrence time of MINS; the second model contained preoperative variables, surgery information, type of anaesthesia and occurrence time of MINS; the third model adjusted all confounders, except cardiovascular complications; and complete analysis was performed finally. Subgroup analysis was conducted in four special groups: participants who underwent cancer surgery, participants except orthopaedic and spine surgery, participants without cardiovascular complications and participants without any complications other than MINS.</p><p>Propensity score weighting (PSW) methods were adopted as sensitivity analysis. A multivariable logistic regression model including all covariates was utilised to calculate the propensity score for inverse probability weighting (IPW) and overlap weighting (OW). Briefly, a weight calculated from multivariable logistic regression was assigned to each subject, resulting in a pseudo-population where baseline characteristics are independent of exposure status. Standardised mean difference (SMD) indicates the difference between varying groups, and effect size indices of 0.2, 0.5 and 0.8 can be used to represent small, medium and large effect sizes, respectively [<xref rid="CIT0015" ref-type="bibr">15</xref>]. All hypothesis tests were two-tailed with a <italic toggle="yes">P</italic>-value of 0.05 or smaller as significant. The statistical analysis was conducted using IBM SPSS Statistics for Windows, Version 25.0 (IBM Corp., Armonk, NY, USA) and R (version 4.4.1, R Foundation for Statistical Computing, Vienna, Austria).</p></sec></sec><sec sec-type="results" disp-level="1" id="S0003"><title>Results</title><sec disp-level="2" id="S0003-S2001"><title>Study population characteristics</title><p>2469 participants were included in the study population (<xref rid="F0001" ref-type="fig">Figure 1</xref>), with a median age of 68&#8201;years, 60.4% male, 65.8% had known cardiovascular comorbidity, 30.7% known diabetes mellitus and 59.4% known cancer and 26.5% participants received orthopaedic or spine surgery. One hundred seventy-eight (7.2%) participants developed MINS within 24&#8201;h after surgery and 83 (3.4%) after 24&#8201;h (<ext-link xlink:href="10.1080/07853890.2025.2552936" ext-link-type="doi">Supplementary Table S2</ext-link>). The 378 (15.3%) participants who suffered disability at 180&#8201;days after surgery were older, smoked less often, were more often diagnosed with cancer and were characterised by lower preoperative levels of albumin and haemoglobin. Patients who experienced MINS, regardless of whether within or after 24&#8201;h, were those who suffered AKI, infection, pulmonary complications or major bleeding more during hospitalisation (<ext-link xlink:href="10.1080/07853890.2025.2552936" ext-link-type="doi">Supplementary Table S2</ext-link>). Detailed characteristics are provided in <xref rid="t0001" ref-type="table">Table 1</xref>.</p><fig position="float" id="F0001" orientation="portrait"><label>Figure 1.</label><caption><p>Flowchart of the study.</p></caption><graphic content-type="color" position="float" orientation="portrait" xlink:href="IANN_A_2552936_F0001_C.jpg"/></fig><table-wrap position="float" id="t0001" orientation="portrait"><label>Table 1.</label><caption><p>Characteristics of participants stratified by disability.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="80pt" span="1"/><col width="80pt" span="1"/><col width="80pt" span="1"/><col width="80pt" span="1"/><col width="80pt" span="1"/><col width="80pt" span="1"/></colgroup><thead><tr><th align="left" colspan="1" rowspan="1">&#160;</th><th align="center" colspan="1" rowspan="1">All <italic toggle="yes">n</italic>&#8201;=&#8201;2469</th><th align="center" colspan="1" rowspan="1">Without disability <italic toggle="yes">n</italic>&#8201;=&#8201;2091 (84.7%)</th><th align="center" colspan="1" rowspan="1">With disability <italic toggle="yes">n</italic>&#8201;=&#8201;378(15.3%)</th><th align="center" colspan="1" rowspan="1"><italic toggle="yes">P</italic>-value</th><th align="center" colspan="1" rowspan="1">SMD</th></tr></thead><tbody valign="top"><tr><td align="left" colspan="1" rowspan="1">Age (years)</td><td align="char" char="." colspan="1" rowspan="1">68.0 (63.0,74.0)</td><td align="char" char="." colspan="1" rowspan="1">68.0 (62.0,73.0)</td><td align="char" char="." colspan="1" rowspan="1">71.0 (66.0,77.0)</td><td align="char" char="." colspan="1" rowspan="1">&lt;0.001</td><td align="char" char="." colspan="1" rowspan="1">0.432</td></tr><tr><td align="left" colspan="1" rowspan="1">Female</td><td align="char" char="." colspan="1" rowspan="1">977(39.5)</td><td align="char" char="." colspan="1" rowspan="1">835 (39.9)</td><td align="char" char="." colspan="1" rowspan="1">142 (37.6)</td><td align="char" char="." colspan="1" rowspan="1">0.419</td><td align="char" char="." colspan="1" rowspan="1">0.049</td></tr><tr><td align="left" colspan="1" rowspan="1">BMI, kg/m<sup>2</sup></td><td align="char" char="." colspan="1" rowspan="1">23.1 (20.8,25.5)</td><td align="char" char="." colspan="1" rowspan="1">23.3 (21.0, 25.7)</td><td align="char" char="." colspan="1" rowspan="1">21.9 (19.5, 24.6)</td><td align="char" char="." colspan="1" rowspan="1">&lt;0.001</td><td align="char" char="." colspan="1" rowspan="1">0.339</td></tr><tr><td align="left" colspan="1" rowspan="1">Smoking status</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">0.029</td><td align="char" char="." colspan="1" rowspan="1">0.154</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Never</td><td align="char" char="." colspan="1" rowspan="1">1562 (63.3)</td><td align="char" char="." colspan="1" rowspan="1">1308 (62.6)</td><td align="char" char="." colspan="1" rowspan="1">254 (67.2)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Former</td><td align="char" char="." colspan="1" rowspan="1">270 (10.9)</td><td align="char" char="." colspan="1" rowspan="1">223 (10.7)</td><td align="char" char="." colspan="1" rowspan="1">47 (12.4)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Current</td><td align="char" char="." colspan="1" rowspan="1">637 (25.8)</td><td align="char" char="." colspan="1" rowspan="1">560 (26.8)</td><td align="char" char="." colspan="1" rowspan="1">77 (20.4)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Cardiovascular comorbidities</td><td align="char" char="." colspan="1" rowspan="1">1624 (65.8)</td><td align="char" char="." colspan="1" rowspan="1">1392 (66.6)</td><td align="char" char="." colspan="1" rowspan="1">232 (61.4)</td><td align="char" char="." colspan="1" rowspan="1">0.057</td><td align="char" char="." colspan="1" rowspan="1">0.108</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Chronic obstructive pulmonary disease</td><td align="char" char="." colspan="1" rowspan="1">86 (3.5)</td><td align="char" char="." colspan="1" rowspan="1">68 (3.3)</td><td align="char" char="." colspan="1" rowspan="1">18 (4.8)</td><td align="char" char="." colspan="1" rowspan="1">0.187</td><td align="char" char="." colspan="1" rowspan="1">0.077</td></tr><tr><td align="left" colspan="1" rowspan="1">Diabetes mellitus</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">0.044</td><td align="char" char="." colspan="1" rowspan="1">0.145</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="char" char="." colspan="1" rowspan="1">1713 (69.4)</td><td align="char" char="." colspan="1" rowspan="1">1431 (68.4)</td><td align="char" char="." colspan="1" rowspan="1">282 (74.6)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Diabetes mellitus on oral drug</td><td align="char" char="." colspan="1" rowspan="1">525 (21.3)</td><td align="char" char="." colspan="1" rowspan="1">455 (21.8)</td><td align="char" char="." colspan="1" rowspan="1">70 (18.5)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Diabetes mellitus on insulin</td><td align="char" char="." colspan="1" rowspan="1">231 (9.4)</td><td align="char" char="." colspan="1" rowspan="1">205 (9.8)</td><td align="char" char="." colspan="1" rowspan="1">26 (6.9)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Liver</td><td align="char" char="." colspan="1" rowspan="1">607 (24.6)</td><td align="char" char="." colspan="1" rowspan="1">515 (24.6)</td><td align="char" char="." colspan="1" rowspan="1">92 (24.3)</td><td align="char" char="." colspan="1" rowspan="1">0.955</td><td align="char" char="." colspan="1" rowspan="1">0.007</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Cancer</td><td align="char" char="." colspan="1" rowspan="1">1467 (59.4)</td><td align="char" char="." colspan="1" rowspan="1">1209 (57.8)</td><td align="char" char="." colspan="1" rowspan="1">258 (68.3)</td><td align="char" char="." colspan="1" rowspan="1">&lt;0.001</td><td align="char" char="." colspan="1" rowspan="1">0.217</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;eGFR, mL/min</td><td align="char" char="." colspan="1" rowspan="1">84.4 (69.5,92.7)</td><td align="char" char="." colspan="1" rowspan="1">84.7 (69.8, 92.9)</td><td align="char" char="." colspan="1" rowspan="1">82.3 (67.62, 90.9)</td><td align="char" char="." colspan="1" rowspan="1">0.016</td><td align="char" char="." colspan="1" rowspan="1">0.128</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Albumin, g/L</td><td align="char" char="." colspan="1" rowspan="1">38.0 (35.0,40.6)</td><td align="char" char="." colspan="1" rowspan="1">38.3 (35.4, 40.8)</td><td align="char" char="." colspan="1" rowspan="1">36.3 (33.5, 38.8)</td><td align="char" char="." colspan="1" rowspan="1">&lt;0.001</td><td align="char" char="." colspan="1" rowspan="1">0.434</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Haemoglobin, g/L</td><td align="char" char="." colspan="1" rowspan="1">123.0 (107.0,135.0)</td><td align="char" char="." colspan="1" rowspan="1">124.0 (109.0, 136.0)</td><td align="char" char="." colspan="1" rowspan="1">113.0 (97.0, 129.0)</td><td align="char" char="." colspan="1" rowspan="1">&lt;0.001</td><td align="char" char="." colspan="1" rowspan="1">0.423</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Minimally invasive surgery</td><td align="char" char="." colspan="1" rowspan="1">1470 (59.5)</td><td align="char" char="." colspan="1" rowspan="1">1295 (61.9)</td><td align="char" char="." colspan="1" rowspan="1">175 (46.3)</td><td align="char" char="." colspan="1" rowspan="1">&lt;0.001</td><td align="char" char="." colspan="1" rowspan="1">0.318</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Blood transfusion during surgery</td><td align="char" char="." colspan="1" rowspan="1">275 (11.1)</td><td align="char" char="." colspan="1" rowspan="1">205 (9.8)</td><td align="char" char="." colspan="1" rowspan="1">70 (18.5)</td><td align="char" char="." colspan="1" rowspan="1">&lt;0.001</td><td align="char" char="." colspan="1" rowspan="1">0.252</td></tr><tr><td align="left" colspan="1" rowspan="1">Type of surgery</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&lt;0.001</td><td align="char" char="." colspan="1" rowspan="1">0.410</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Foregut or hepatopancreatobiliary</td><td align="char" char="." colspan="1" rowspan="1">566 (22.9)</td><td align="char" char="." colspan="1" rowspan="1">461 (22.0)</td><td align="char" char="." colspan="1" rowspan="1">105 (27.8)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Intestinal</td><td align="char" char="." colspan="1" rowspan="1">480 (19.4)</td><td align="char" char="." colspan="1" rowspan="1">394 (18.8)</td><td align="char" char="." colspan="1" rowspan="1">86 (22.8)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Orthopaedic</td><td align="char" char="." colspan="1" rowspan="1">434 (17.6)</td><td align="char" char="." colspan="1" rowspan="1">353 (16.9)</td><td align="char" char="." colspan="1" rowspan="1">81 (21.4)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Thoracic(nonoesophageal)</td><td align="char" char="." colspan="1" rowspan="1">371 (15.0)</td><td align="char" char="." colspan="1" rowspan="1">340 (16.3)</td><td align="char" char="." colspan="1" rowspan="1">31 (8.2)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Urological</td><td align="char" char="." colspan="1" rowspan="1">250 (10.1)</td><td align="char" char="." colspan="1" rowspan="1">219 (10.5)</td><td align="char" char="." colspan="1" rowspan="1">31 (8.2)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Spine</td><td align="char" char="." colspan="1" rowspan="1">219 (8.9)</td><td align="char" char="." colspan="1" rowspan="1">206 (9.9)</td><td align="char" char="." colspan="1" rowspan="1">13 (3.4)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Other<sup>a</sup></td><td align="char" char="." colspan="1" rowspan="1">149 (6.0)</td><td align="char" char="." colspan="1" rowspan="1">118 (5.6)</td><td align="char" char="." colspan="1" rowspan="1">31 (8.2)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">Type of anaesthesia</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">0.002</td><td align="char" char="." colspan="1" rowspan="1">0.185</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Regional anaesthesia alone</td><td align="char" char="." colspan="1" rowspan="1">269 (10.9)</td><td align="char" char="." colspan="1" rowspan="1">208 (9.9)</td><td align="char" char="." colspan="1" rowspan="1">61 (16.1)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;General plus regional anaesthesia</td><td align="char" char="." colspan="1" rowspan="1">54 (2.2)</td><td align="char" char="." colspan="1" rowspan="1">47 (2.2)</td><td align="char" char="." colspan="1" rowspan="1">7 (1.9)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;General anaesthesia alone</td><td align="char" char="." colspan="1" rowspan="1">2146 (86.9)</td><td align="char" char="." colspan="1" rowspan="1">1836 (87.8)</td><td align="char" char="." colspan="1" rowspan="1">310 (82.0)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">MINS</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&lt;0.001</td><td align="char" char="." colspan="1" rowspan="1">0.260</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="char" char="." colspan="1" rowspan="1">2208 (89.4)</td><td align="char" char="." colspan="1" rowspan="1">1896 (90.7)</td><td align="char" char="." colspan="1" rowspan="1">312 (82.5)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Within 24&#8201;h</td><td align="char" char="." colspan="1" rowspan="1">178 (7.2)</td><td align="char" char="." colspan="1" rowspan="1">140 (6.7)</td><td align="char" char="." colspan="1" rowspan="1">38 (10.1)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;After 24&#8201;h</td><td align="char" char="." colspan="1" rowspan="1">83 (3.4)</td><td align="char" char="." colspan="1" rowspan="1">55 (2.6)</td><td align="char" char="." colspan="1" rowspan="1">28 (7.4)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Cardiovascular complications</td><td align="char" char="." colspan="1" rowspan="1">98 (4.0)</td><td align="char" char="." colspan="1" rowspan="1">60 (2.9)</td><td align="char" char="." colspan="1" rowspan="1">38 (10.1)</td><td align="char" char="." colspan="1" rowspan="1">&lt;0.001</td><td align="char" char="." colspan="1" rowspan="1">0.295</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;AKI</td><td align="char" char="." colspan="1" rowspan="1">180 (7.3)</td><td align="char" char="." colspan="1" rowspan="1">140 (6.7)</td><td align="char" char="." colspan="1" rowspan="1">40 (10.6)</td><td align="char" char="." colspan="1" rowspan="1">0.01</td><td align="char" char="." colspan="1" rowspan="1">0.139</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Infection</td><td align="char" char="." colspan="1" rowspan="1">203 (8.2)</td><td align="char" char="." colspan="1" rowspan="1">143 (6.8)</td><td align="char" char="." colspan="1" rowspan="1">60 (15.9)</td><td align="char" char="." colspan="1" rowspan="1">&lt;0.001</td><td align="char" char="." colspan="1" rowspan="1">0.288</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Pulmonary complications</td><td align="char" char="." colspan="1" rowspan="1">18 (0.7)</td><td align="char" char="." colspan="1" rowspan="1">9 (0.4)</td><td align="char" char="." colspan="1" rowspan="1">9 (2.4)</td><td align="char" char="." colspan="1" rowspan="1">&lt;0.001</td><td align="char" char="." colspan="1" rowspan="1">0.166</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Intestinal complications</td><td align="char" char="." colspan="1" rowspan="1">69 (2.8)</td><td align="char" char="." colspan="1" rowspan="1">48 (2.3)</td><td align="char" char="." colspan="1" rowspan="1">21 (5.6)</td><td align="char" char="." colspan="1" rowspan="1">0.001</td><td align="char" char="." colspan="1" rowspan="1">0.168</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Major bleeding</td><td align="char" char="." colspan="1" rowspan="1">81 (3.3)</td><td align="char" char="." colspan="1" rowspan="1">56 (2.7)</td><td align="char" char="." colspan="1" rowspan="1">25 (6.6)</td><td align="char" char="." colspan="1" rowspan="1">&lt;0.001</td><td align="char" char="." colspan="1" rowspan="1">0.188</td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p>Values in parentheses are percentages or interquartile ranges.</p></fn><fn id="TF2"><p><sup>a</sup>Included gynaecologic (81, 54.3%), head and neck (47, 31.5%) and vascular (21,14.1%) surgeries.</p></fn></table-wrap-foot></table-wrap></sec><sec disp-level="2" id="S0003-S2002"><title>Association between occurrence time of MINS and disability at 180&#8201;days after surgery</title><p>The results of multivariable logistic regression models for the association between the occurrence time of MINS and disability risk are shown in <xref rid="t0002" ref-type="table">Table 2</xref>. All VIFs were less than two (<ext-link xlink:href="10.1080/07853890.2025.2552936" ext-link-type="doi">Supplementary Table S3</ext-link>), indicating that no multicollinearity existed among the studied variables. In model 1, in which any other confounders were unadjusted, MINS occurring within 24&#8201;h after surgery was positively associated with disability at 180&#8201;days after surgery (odds ratio [OR]: 1.65, 95% confidence intervals [CIs]: 1.13&#8211;2.40, <italic toggle="yes">P</italic>&#8201;=&#8201;0.009), the effect size decreased gradually as more information was considered in subsequent models; As a contrast, MINS occurring after 24&#8201;h was positively associated with outcome in all models, whose effect lessened by degrees with covariable regulation. Interestingly, similar effects were observed in models 3 (OR: 2.09, 95%CIs: 1.25&#8211;3.48, <italic toggle="yes">P</italic>&#8201;=&#8201;0.005) and 4 (OR: 1.97, 95%CIs: 1.17&#8211;3.32, <italic toggle="yes">P</italic>&#8201;=&#8201;0.01), that is, the effect of MINS occurring after 24&#8201;h was stable whether postoperative cardiovascular complications were considered or not.</p><table-wrap position="float" id="t0002" orientation="portrait"><label>Table 2.</label><caption><p>Association between occurrence time of MINS and disability at 180&#8201;days based on logistic regression.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="80pt" span="1"/><col width="80pt" span="1"/><col width="80pt" span="1"/><col width="80pt" span="1"/><col width="80pt" span="1"/></colgroup><thead><tr><th align="left" colspan="1" rowspan="1">&#160;</th><th align="center" colspan="1" rowspan="1">Model 1</th><th align="center" colspan="1" rowspan="1">Model 2</th><th align="center" colspan="1" rowspan="1">Model 3</th><th align="center" colspan="1" rowspan="1">Model 4</th></tr></thead><tbody valign="top"><tr><td align="left" colspan="1" rowspan="1">MINS</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="center" colspan="1" rowspan="1">Ref</td><td align="center" colspan="1" rowspan="1">Ref</td><td align="center" colspan="1" rowspan="1">Ref</td><td align="center" colspan="1" rowspan="1">Ref</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Within 24h, OR (95% CI), <italic toggle="yes">P</italic></td><td align="char" char="." colspan="1" rowspan="1">1.65 (1.13,2.40), 0.009</td><td align="char" char="." colspan="1" rowspan="1">1.16 (0.77, 1.74), 0.481</td><td align="char" char="." colspan="1" rowspan="1">1.06(0.70,1.60), 0.785</td><td align="char" char="." colspan="1" rowspan="1">0.97(0.63,1.47), 0.865</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;After 24h, OR (95% CI), <italic toggle="yes">P</italic></td><td align="char" char="." colspan="1" rowspan="1">3.09 (1.93,4.95), &lt;0.001</td><td align="char" char="." colspan="1" rowspan="1">2.23 (1.34,3.71), 0.002</td><td align="char" char="." colspan="1" rowspan="1">2.089(1.25,3.48), 0.005</td><td align="char" char="." colspan="1" rowspan="1">1.97(1.17,3.32), 0.010</td></tr></tbody></table></table-wrap></sec><sec disp-level="2" id="S0003-S2003"><title>Association between occurrence time of MINS and disability at 180&#8201;days after surgery using PSW regression</title><p>Maximal SMD of each baseline before and after PSW as shown in <ext-link xlink:href="10.1080/07853890.2025.2552936" ext-link-type="doi">Table S2</ext-link>. Participants with MINS 24&#8201;h after surgery were more likely older, smoked less often and had lower levels of albumin and haemoglobin before surgery. Participants who developed MINS, whether within or after 24&#8201;h, seemed to experience higher risk of other complications (<ext-link xlink:href="10.1080/07853890.2025.2552936" ext-link-type="doi">Table S2</ext-link>). The results of multivariate logistic regression analysis based on pseudo-population generated by IPW or OW mirrored the results of unweighted analysis (<xref rid="t0003" ref-type="table">Tables 3</xref> and <xref rid="t0004" ref-type="table">4</xref>), the 95%CIs of effect size for MINS within 24&#8201;h crossed 1 in all the model.</p><table-wrap position="float" id="t0003" orientation="portrait"><label>Table 3.</label><caption><p>Association between occurrence time of MINS and disability at 180&#8201;days after surgery using propensity score IPW regression.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="80pt" span="1"/><col width="80pt" span="1"/><col width="80pt" span="1"/><col width="80pt" span="1"/><col width="80pt" span="1"/></colgroup><thead><tr><th align="left" colspan="1" rowspan="1">&#160;</th><th align="center" colspan="1" rowspan="1">Model 1</th><th align="center" colspan="1" rowspan="1">Model 2</th><th align="center" colspan="1" rowspan="1">Model 3</th><th align="center" colspan="1" rowspan="1">Model 4</th></tr></thead><tbody valign="top"><tr><td align="left" colspan="1" rowspan="1">MINS</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="center" colspan="1" rowspan="1">Ref</td><td align="center" colspan="1" rowspan="1">Ref</td><td align="center" colspan="1" rowspan="1">Ref</td><td align="center" colspan="1" rowspan="1">Ref</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Within 24&#8201;h, OR (95% CI), <italic toggle="yes">P</italic></td><td align="char" char="." colspan="1" rowspan="1">0.70 (0.43,1.33), 0.145</td><td align="char" char="." colspan="1" rowspan="1">0.66 (0.39,1.10), 0.111</td><td align="char" char="." colspan="1" rowspan="1">0.64 (0.38,1.10), 0.089</td><td align="char" char="." colspan="1" rowspan="1">0.64 (0.38,1.10), 0.094</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;After 24&#8201;h, OR (95% CI), <italic toggle="yes">P</italic></td><td align="char" char="." colspan="1" rowspan="1">1.92 (0.98,3.79), 0.059</td><td align="char" char="." colspan="1" rowspan="1">2.13 (1.04,4.36), 0.038</td><td align="char" char="." colspan="1" rowspan="1">2.24 (1.09,4.59), 0.028</td><td align="char" char="." colspan="1" rowspan="1">2.25 (1.10,4.63), 0.027</td></tr></tbody></table></table-wrap><table-wrap position="float" id="t0004" orientation="portrait"><label>Table 4.</label><caption><p>Association between occurrence time of MINS and disability at 180&#8201;days after surgery using propensity score OW regression.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="80pt" span="1"/><col width="80pt" span="1"/><col width="80pt" span="1"/><col width="80pt" span="1"/><col width="80pt" span="1"/></colgroup><thead><tr><th align="left" colspan="1" rowspan="1">&#160;</th><th align="center" colspan="1" rowspan="1">Model 1</th><th align="center" colspan="1" rowspan="1">Model 2</th><th align="center" colspan="1" rowspan="1">Model 3</th><th align="center" colspan="1" rowspan="1">Model 4</th></tr></thead><tbody valign="top"><tr><td align="left" colspan="1" rowspan="1">MINS</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="center" colspan="1" rowspan="1">Ref</td><td align="center" colspan="1" rowspan="1">Ref</td><td align="center" colspan="1" rowspan="1">Ref</td><td align="center" colspan="1" rowspan="1">Ref</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Within 24&#8201;h, OR (95% CI), <italic toggle="yes">P</italic></td><td align="center" char="." colspan="1" rowspan="1">0.96 (0.62,1.52), 0.888</td><td align="left" colspan="1" rowspan="1">0.91 (0.55,1.49), 0.705</td><td align="left" colspan="1" rowspan="1">0.91 (0.54,1.51), 0.0.70846</td><td align="center" char="." colspan="1" rowspan="1">0.88 (0.53,1.49), 0.652</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;After 24&#8201;h, OR (95% CI), <italic toggle="yes">P</italic></td><td align="center" char="." colspan="1" rowspan="1">1.80 (1.07,3.01), 0.026</td><td align="left" colspan="1" rowspan="1">2.02 (1.17,3.48), 0.011</td><td align="left" colspan="1" rowspan="1">2.13 (1.24,3.65), 0.00609</td><td align="center" char="." colspan="1" rowspan="1">2.11 (1.23,3.63), 0.007</td></tr></tbody></table></table-wrap></sec><sec disp-level="2" id="S0003-S2004"><title>Subgroup analysis</title><p>Subgroup analysis, conducted on all covariates using a fully adjusted logistic regression model, shared similar results with the models above. As shown in <xref rid="F0002" ref-type="fig">Figure 2</xref>, in the all four models, the OR for MINS after 24&#8201;h consistently demonstrated an effect size around 2, whereas the 95%CIs for MINS within 24&#8201;h crossed 1.</p><fig position="float" id="F0002" orientation="portrait"><label>Figure 2.</label><caption><p>Subgroup analysis of the association between occurrence time of MINS and disability at 180&#8201;days after surgery.</p></caption><graphic content-type="black-white" position="float" orientation="portrait" xlink:href="IANN_A_2552936_F0002_B.jpg"/></fig></sec></sec><sec sec-type="discussion" disp-level="1" id="S0004"><title>Discussion</title><p>This prospective cohort study of patients with cardiovascular risk investigated the relationship between different occurrence time of MINS and disability at 180&#8201;days after major noncardiac surgery. In our analysis, patients with MINS were stratified in two groups on the basis of the occurrence time of MINS, namely, within 24&#8201;h or after 24&#8201;h, referring to the elimination rate for troponin T in NTEMI patients [<xref rid="CIT0016" ref-type="bibr">16</xref>]. This study revealed that MINS occurring after 24&#8201;h was associated with deteriorated long-term functional capacity, regardless of the cases with or without postoperative cardiovascular complications.</p><p>Participants who underwent cancer surgery and orthopaedic or spine surgery experienced more intense fluctuation in functional capacity than those who had other noncardiac surgeries. The former usually encountered little confusion in ordinary life but suffered severe disability after surgery, whereas the latter often experienced oppositely. In our study, only 94 (14.4%) of the participants who underwent orthopaedic and spine surgeries and developed disability were underpowered to build a logistic model. Accordingly, subgroup analysis was performed on the basis of the complementary population in compromise.</p><p>Research on the kinetics of troponin T in MINS is limited. Evidence from acute myocardial infarction may shed some light on the explanation of our conclusion. When an ischaemic attack leads to imbalance between oxygen supply and demand, lactic acid accumulation in cardiomyocytes results in acidification of the intracellular environment (&#8764;22&#8211;37&#8201;h after MI), which activates proteolytic and apoptotic enzymes. Troponin T is broken down into smaller fragments, which could pass through the intact cell membrane, and some of them with certain part are detected as whole troponin T by current commercial troponin T assay [<xref rid="CIT0017" ref-type="bibr">17</xref>,<xref rid="CIT0018" ref-type="bibr">18</xref>]. A study showed that the degree of proteolytic degradation increased with increasing severity of myocardial injury, as estimated by the total troponin level [<xref rid="CIT0019" ref-type="bibr">19</xref>]. On the basis of the above findings, we speculated that patients with MINS 24&#8201;h after surgery have higher ratio of proteolytic fragments keeping certain stable part, which reflects more deteriorated intracellular environment and worse prognosis.</p><p>Our finding is consistent with that of a subanalysis of the ENIGMA-II trial, in which troponin elevation, excluding extracardiac aetiology, with or without any postoperative adverse events, was associated with worse presence of Katz activities of daily living inventory, reflecting overall performance in fundamental physical activity [<xref rid="CIT0020" ref-type="bibr">20</xref>]. Disability in this research, defined by a more comprehensive scale, was measured using the telephone-based version of WHODAS 2.0, containing six important domains, namely, cognition, mobility, self-care, interpersonal relationships, work and household roles and participation in society, which has been evaluated in diverse surgical cohort with different degrees of comorbidity [<xref rid="CIT0014" ref-type="bibr">14</xref>]. Meanwhile, elevated troponin levels are independently associated with self-reported health status (assessed by EuroQol five-dimensional questionnaire, EQ-5D) 1&#8201;year after surgery [<xref rid="CIT0021" ref-type="bibr">21</xref>]. Whilst both EQ-5D and WHODAS 2.0 are assessments recommended by StEP-COMPAC working group to evaluate patient-centred outcomes, EQ-5D is a measure of health-related quality of life, and the latter is a measure of functional outcome; WHODAS 2.0 was classified under the same domain with EQ-5D for the entire Delphi consensus process until the final stage [<xref rid="CIT0012" ref-type="bibr">12</xref>]. Although functional capacity certainly affects quality of life, items in the two measurements are overlapping in some degree. Hence, troponin may be a potential biomarker for predicting recovery quality after a long time, which also helps to answer the questions on patient care and facilitates recovery plans after discharge.</p><p>Despite the varying conclusions drawn from a multicentre cohort study adopting the same disability assessment, patients with troponin exceeding the 99th percentile reported similar disability scores at 6&#8201;months [<xref rid="CIT0022" ref-type="bibr">22</xref>]. The differences in methods and definitions between the two studies should be recognised. The first difference was the threshold of troponin elevation, which was defined as troponin exceeding the 99th percentile of the used assay or an increase of 20% of the preoperative troponin in the multicentre cohort study and a change of at least 5&#8201;ng/L or a postoperative troponin T level of at least 65&#8201;ng/L in the current study. The second difference lies in inclusion criteria. Participants of various age groups were enrolled across centres (i.e. participants aged &#8805;50 or 60&#8201;year, from different hospitals, were enrolled) in that multicentre study. By contrast, our cohort enrolled patients aged &#8805;45&#8201;year with cardiovascular diseases or cardiovascular risk factors scheduled for major noncardiac surgery, alike to the subanalysis of the ENIGMA-II trial. Peak troponin level was associated with poor long-term prognosis in a dose-dependent manner. However, in this setting, the peak troponin levels in the two studies were difficult to compare directly or indirectly. The negative implications of cardiovascular diseases or cardiovascular risk factors on quality of life and survival were well known. Population difference may be the key to interpreting the discrepancy, with heterogeneity in the threshold of troponin elevation.</p><p>Findings generated from our data provide some implications to clinical practice and further research. Firstly, our data revealed a link between MINS occurring after 24&#8201;h and long-term functional capacity, beyond the prognostic capability of major adverse cardiovascular events or death following surgery [<xref rid="CIT0005" ref-type="bibr">5</xref>]. The misallocation of health care-related resources is a fundamental global issue, in which the high concentration of medical services in economically developed or capital cities stimulates remote health care-seeking behaviour, namely, patients are willing to pay a high price to access high-quality perioperative care [<xref rid="CIT0023" ref-type="bibr">23</xref>,<xref rid="CIT0024" ref-type="bibr">24</xref>]. In actuality, after surgery, patients usually recover shortly during hospitalisation and then experience a long rehabilitation of functional capacity in their home city. Therefore, a suitable expectation of rehabilitation and follow-up plan at the time of discharge could provide patients accurate information, relieve patients&#8217; anxiety and avoid unnecessary follow-up. Our observations suggested that the occurrence time of MINS is an alternative reference to judge functional capacity and facilitate follow-up plan.</p><p>Secondly, this research supports current practice guidelines in recommending routine troponin T surveillance for high-risk individuals in perioperative periods [<xref rid="CIT0006" ref-type="bibr">6&#8211;8</xref>], especially 24&#8201;h postoperatively. Troponin T assay is the only way to detect MINS; however, the implementation of troponin T surveillance is unsatisfactory, even after perioperative troponin monitoring endorsed by relevant professional societies [<xref rid="CIT0025" ref-type="bibr">25</xref>]. Some clinicians argued that troponin testing before surgery is costly and useless, not to mention surveillance in perioperative periods, considering the lack of clinically recognised management strategies [<xref rid="CIT0026" ref-type="bibr">26</xref>]. The recommendation that routine troponin T surveillance is economically acceptable and benefits patients at increased cardiovascular risk was proved in Canadian patients who participated in the VISION study [<xref rid="CIT0027" ref-type="bibr">27</xref>]. Previous study generated from PREVENGE-CB revealed that preoperative troponin T improve the prediction for cardiovascular events within 30&#8201;days after noncardiac surgery and a recent study also revealed that troponin increase facilitates prognostic stratification for patients with non-ST-segment-elevation myocardial infarction after percutaneous coronary intervention [<xref rid="CIT0011" ref-type="bibr">11</xref>,<xref rid="CIT0028" ref-type="bibr">28</xref>]. Another exploration suggested that elevated troponin within 24&#8201;h of elective noncardiac surgery is associated with the development of noncardiac complications and that troponin monitoring potentially offers a real-time assessment tool to assign postoperative care [<xref rid="CIT0010" ref-type="bibr">10</xref>]. Our observation expands that even slight increments in troponin 24&#8201;h postoperatively are prognostically relevant and that routine detection will help flag patients with poor functional capacity in early postoperative periods, although most MINS were diagnosed on the day of surgery or the first postoperative day [<xref rid="CIT0005" ref-type="bibr">5</xref>]. Thirdly, our conclusion reinforces the significance of understanding pathophysiology of MINS and mechanisms underlying troponin T release in perioperative periods and appeals to complement patient-centred outcomes in further study.</p><p>To the best of our knowledge, this is the first study to explore the association between different occurrence time of MINS and disability at 180&#8201;days after major noncardiac surgery. In this cohort, a high satisfactory rate of troponin T surveillance completeness of &gt;98% was achieved, before and after surgery, and telephone follow-up response rate (&gt;92%) was also high at 180&#8201;days after surgery. However, the observational design limits bias control, this cohort did not involve information on the time frame or occurrence time of other postoperative adverse events and type of cancer, some other pathophysiological processes may cause severe damage to long-term functional capacity, malignant tumor and subsequent treatment undoubtly worsen quality of life. This cohort only measured troponin T obligatorily on the first second days after surgery, the subsequent postoperative troponin T was tested based on clinical necessity, which may result in the omission of MINS after 24&#8201;h. Besides, the generalisability of our findings may be limited to population with increased cardiovascular risk undergoing major surgery, disability associated with MINS occurring in lower risk patients and patients undergoing minor surgery still unknown. Furthermore, the exposure grouping stratified according to the kinetics of troponin T in acute myocardial infarction may be controversial, although the aetiologies of MINS and acute myocardial infarction are both related to myocardial ischemia.</p></sec><sec sec-type="conclusions" disp-level="1" id="S0005"><title>Conclusion</title><p>In summary, MINS occurring after 24&#8201;h deteriorates the long-term functional capacity in high-cardiovascular-risk population, regardless of whether it is accompanied by other complications or not. A proactive perioperative troponin T surveillance strategy for high-risk population, especially measurement 24&#8201;h postoperatively, provides an objective reference to stratify recovery of long-term functional capacity and facilitate follow-up schedule.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="SM2926" position="float" content-type="local-data" orientation="portrait"><caption><title>Supplementary material.docx</title></caption><media xlink:href="IANN_A_2552936_SM2926.docx" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack><title>Acknowledgements</title><p>The authors express their sincere gratitude to the PREVENGE-CB Collaborators (Shao-Hui Lei, M.D., Pei-Pei Zhuang, M.D., Xiao Yang, M.D., Wei-Jie Feng, M.D., Shi-Da Qiu, M.D., Huan Yang, M.D and Yi-Shan Xie, M.D.) for their dedicated evaluation in data collection.</p></ack><sec sec-type="COI-statement" disp-level="1" id="S0006"><title>Disclosure statement</title><p>The authors declare that they have no conflicts of interest.</p></sec><sec sec-type="data-availability" disp-level="1" id="S0008"><title>Data availability statement</title><p>The datasets generated and analysed during the current study are not publicly available because of the Nanfang Hospital regulations but are available from the corresponding author Ke-Xuan Liu on reasonable request.</p></sec><ref-list><title>References</title><ref id="CIT0001"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Weiser</surname><given-names>TG</given-names></string-name>, <string-name name-style="western"><surname>Haynes</surname><given-names>AB</given-names></string-name>, <string-name name-style="western"><surname>Molina</surname><given-names>G</given-names></string-name>, <etal>et al.</etal></person-group><article-title>Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes</article-title>. <source>Lancet</source>. <year>2015</year>;<volume>385 Suppl 2</volume>(<issue>Suppl 2</issue>):<fpage>S11</fpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(15)60806-6</pub-id>.<pub-id pub-id-type="pmid">26313057</pub-id></mixed-citation></ref><ref id="CIT0002"><label>2</label><mixed-citation publication-type="journal"><article-title>Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries</article-title>. <source>Br J Anaesth</source>. <year>2016</year>;<volume>117</volume>(<issue>5</issue>):<fpage>601</fpage>&#8211;<lpage>609</lpage>. doi: <pub-id pub-id-type="doi">10.1093/bja/aew316</pub-id>.<pub-id pub-id-type="pmid">27799174</pub-id><pub-id pub-id-type="pmcid">PMC5091334</pub-id></mixed-citation></ref><ref id="CIT0003"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ladha</surname><given-names>KS</given-names></string-name>, <string-name name-style="western"><surname>Wijeysundera</surname><given-names>DN.</given-names></string-name></person-group><article-title>Role of patient-centred outcomes after hospital discharge: a state-of-the-art review</article-title>. <source>Anaesthesia</source>. <year>2020</year>;<volume>75 Suppl 1</volume>(<issue>S1</issue>):<fpage>e151</fpage>&#8211;<lpage>e157</lpage>. doi: <pub-id pub-id-type="doi">10.1111/anae.14903</pub-id>.<pub-id pub-id-type="pmid">31903568</pub-id></mixed-citation></ref><ref id="CIT0004"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Myles</surname><given-names>PS.</given-names></string-name></person-group><article-title>More than just morbidity and mortality &#8211; quality of recovery and long-term functional recovery after surgery</article-title>. <source>Anaesthesia</source>. <year>2020</year>;<volume>75 Suppl 1</volume>(<issue>S1</issue>):<fpage>e143</fpage>&#8211;<lpage>e150</lpage>. doi: <pub-id pub-id-type="doi">10.1111/anae.14786</pub-id>.<pub-id pub-id-type="pmid">31903564</pub-id></mixed-citation></ref><ref id="CIT0005"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Devereaux</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Biccard</surname><given-names>BM</given-names></string-name>, <string-name name-style="western"><surname>Sigamani</surname><given-names>A</given-names></string-name>, <etal>et al.</etal></person-group><article-title>Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery</article-title>. <source>JAMA</source>. <year>2017</year>;<volume>317</volume>(<issue>16</issue>):<fpage>1642</fpage>&#8211;<lpage>1651</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2017.4360</pub-id>.<pub-id pub-id-type="pmid">28444280</pub-id></mixed-citation></ref><ref id="CIT0006"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Halvorsen</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Mehilli</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Cassese</surname><given-names>S</given-names></string-name>, <etal>et al.</etal></person-group><article-title>2022 ESC guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery</article-title>. <source>Eur Heart J</source>. <year>2022</year>;<volume>43</volume>(<issue>39</issue>):<fpage>3826</fpage>&#8211;<lpage>3924</lpage>. doi: <pub-id pub-id-type="doi">10.1093/eurheartj/ehac270</pub-id>.<pub-id pub-id-type="pmid">36017553</pub-id></mixed-citation></ref><ref id="CIT0007"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ruetzler</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Smilowitz</surname><given-names>NR</given-names></string-name>, <string-name name-style="western"><surname>Berger</surname><given-names>JS</given-names></string-name>, <etal>et al.</etal></person-group><article-title>Diagnosis and management of patients with myocardial injury after noncardiac surgery: a scientific statement from the American heart association</article-title>. <source>Circulation</source>. <year>2021</year>;<volume>144</volume>(<issue>19</issue>):<fpage>e287</fpage>&#8211;<lpage>e305</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIR.0000000000001024</pub-id>.<pub-id pub-id-type="pmid">34601955</pub-id></mixed-citation></ref><ref id="CIT0008"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Duceppe</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Parlow</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>MacDonald</surname><given-names>P</given-names></string-name>, <etal>et al.</etal></person-group><article-title>Canadian cardiovascular society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery</article-title>. <source>Can J Cardiol</source>. <year>2017</year>;<volume>33</volume>(<issue>1</issue>):<fpage>17</fpage>&#8211;<lpage>32</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cjca.2016.09.008</pub-id>.<pub-id pub-id-type="pmid">27865641</pub-id></mixed-citation></ref><ref id="CIT0009"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Maile</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Jewell</surname><given-names>ES</given-names></string-name>, <string-name name-style="western"><surname>Engoren</surname><given-names>MC.</given-names></string-name></person-group><article-title>Timing of preoperative troponin elevations and postoperative mortality after noncardiac surgery</article-title>. <source>Anesth Analg</source>. <year>2016</year>;<volume>123</volume>(<issue>1</issue>):<fpage>135</fpage>&#8211;<lpage>140</lpage>. doi: <pub-id pub-id-type="doi">10.1213/ANE.0000000000001309</pub-id>.<pub-id pub-id-type="pmid">27314692</pub-id></mixed-citation></ref><ref id="CIT0010"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ackland</surname><given-names>GL</given-names></string-name>, <string-name name-style="western"><surname>Abbott</surname><given-names>TEF</given-names></string-name>, <string-name name-style="western"><surname>Jones</surname><given-names>TF</given-names></string-name>, <etal>et al.</etal></person-group><article-title>Early elevation in plasma high-sensitivity troponin T and morbidity after elective noncardiac surgery: prospective multicentre observational cohort study</article-title>. <source>Br J Anaesth</source>. <year>2020</year>;<volume>124</volume>(<issue>5</issue>):<fpage>535</fpage>&#8211;<lpage>543</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bja.2020.02.003</pub-id>.<pub-id pub-id-type="pmid">32147104</pub-id><pub-id pub-id-type="pmcid">PMC7222220</pub-id></mixed-citation></ref><ref id="CIT0011"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zhao</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Lei</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Zhuang</surname><given-names>P</given-names></string-name>, <etal>et al.</etal></person-group><article-title>Preoperative N-terminal pro-B-type natriuretic peptide and high-sensitivity cardiac troponin T and outcomes after major noncardiac surgery: a prospective cohort study</article-title>. <source>Anesthesiology</source>. <year>2024</year>;<volume>141</volume>(<issue>3</issue>):<fpage>475</fpage>&#8211;<lpage>488</lpage>. doi: <pub-id pub-id-type="doi">10.1097/ALN.0000000000005073</pub-id>.<pub-id pub-id-type="pmid">38753984</pub-id></mixed-citation></ref><ref id="CIT0012"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Moonesinghe</surname><given-names>SR</given-names></string-name>, <string-name name-style="western"><surname>Jackson</surname><given-names>AIR</given-names></string-name>, <string-name name-style="western"><surname>Boney</surname><given-names>O</given-names></string-name>, <etal>et al.</etal></person-group><article-title>Systematic review and consensus definitions for the standardised endpoints in perioperative medicine initiative: patient-centred outcomes</article-title>. <source>Br J Anaesth</source>. <year>2019</year>;<volume>123</volume>(<issue>5</issue>):<fpage>664</fpage>&#8211;<lpage>670</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bja.2019.07.020</pub-id>.<pub-id pub-id-type="pmid">31493848</pub-id></mixed-citation></ref><ref id="CIT0013"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Shulman</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Kasza</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Myles</surname><given-names>PS.</given-names></string-name></person-group><article-title>Defining the minimal clinically important difference and patient-acceptable symptom state score for disability assessment in surgical patients</article-title>. <source>Anesthesiology</source>. <year>2020</year>;<volume>132</volume>(<issue>6</issue>):<fpage>1362</fpage>&#8211;<lpage>1370</lpage>. doi: <pub-id pub-id-type="doi">10.1097/ALN.0000000000003240</pub-id>.<pub-id pub-id-type="pmid">32167984</pub-id></mixed-citation></ref><ref id="CIT0014"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Shulman</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Myles</surname><given-names>PS</given-names></string-name>, <string-name name-style="western"><surname>Chan</surname><given-names>MTV</given-names></string-name>, <etal>et al.</etal></person-group><article-title>Measurement of disability-free survival after surgery</article-title>. <source>Anesthesiology</source>. <year>2015</year>;<volume>122</volume>(<issue>3</issue>):<fpage>524</fpage>&#8211;<lpage>536</lpage>. doi: <pub-id pub-id-type="doi">10.1097/ALN.0000000000000586</pub-id>.<pub-id pub-id-type="pmid">25689757</pub-id></mixed-citation></ref><ref id="CIT0015"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Austin</surname><given-names>PC.</given-names></string-name></person-group><article-title>Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples</article-title>. <source>Stat Med</source>. <year>2009</year>;<volume>28</volume>(<issue>25</issue>):<fpage>3083</fpage>&#8211;<lpage>3107</lpage>. doi: <pub-id pub-id-type="doi">10.1002/sim.3697</pub-id>.<pub-id pub-id-type="pmid">19757444</pub-id><pub-id pub-id-type="pmcid">PMC3472075</pub-id></mixed-citation></ref><ref id="CIT0016"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>van Doorn</surname><given-names>WPTM</given-names></string-name>, <string-name name-style="western"><surname>Vroemen</surname><given-names>WHM</given-names></string-name>, <string-name name-style="western"><surname>Smulders</surname><given-names>MW</given-names></string-name>, <etal>et al.</etal></person-group><article-title>High-sensitivity cardiac troponin I and T kinetics after non-ST-segment elevation myocardial infarction</article-title>. <source>J Appl Lab Med</source>. <year>2020</year>;<volume>5</volume>(<issue>1</issue>):<fpage>239</fpage>&#8211;<lpage>241</lpage>. doi: <pub-id pub-id-type="doi">10.1373/jalm.2019.029785</pub-id>.<pub-id pub-id-type="pmid">32445337</pub-id></mixed-citation></ref><ref id="CIT0017"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chaulin</surname><given-names>AM.</given-names></string-name></person-group><article-title>Cardiac troponins metabolism: from biochemical mechanisms to clinical practice (literature review)</article-title>. <source>Int J Mol Sci</source>. <year>2021</year>;<volume>22</volume>(<issue>20</issue>):<fpage>10928</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms222010928</pub-id>.<pub-id pub-id-type="pmid">34681585</pub-id><pub-id pub-id-type="pmcid">PMC8535601</pub-id></mixed-citation></ref><ref id="CIT0018"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Katrukha</surname><given-names>IA</given-names></string-name>, <string-name name-style="western"><surname>Riabkova</surname><given-names>NS</given-names></string-name>, <string-name name-style="western"><surname>Kogan</surname><given-names>AE</given-names></string-name>, <etal>et al.</etal></person-group><article-title>Fragmentation of human cardiac troponin T after acute myocardial infarction</article-title>. <source>Clin Chim Acta</source>. <year>2023</year>;<volume>542</volume>:<fpage>117281</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cca.2023.117281</pub-id>.<pub-id pub-id-type="pmid">36918061</pub-id></mixed-citation></ref><ref id="CIT0019"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zahran</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Figueiredo</surname><given-names>VP</given-names></string-name>, <string-name name-style="western"><surname>Graham</surname><given-names>MM</given-names></string-name>, <etal>et al.</etal></person-group><article-title>Proteolytic digestion of serum cardiac troponin I as marker of ischemic severity</article-title>. <source>J Appl Lab Med</source>. <year>2018</year>;<volume>3</volume>(<issue>3</issue>):<fpage>450</fpage>&#8211;<lpage>455</lpage>. doi: <pub-id pub-id-type="doi">10.1373/jalm.2017.025254</pub-id>.<pub-id pub-id-type="pmid">33636927</pub-id></mixed-citation></ref><ref id="CIT0020"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Beattie</surname><given-names>WS</given-names></string-name>, <string-name name-style="western"><surname>Wijeysundera</surname><given-names>DN</given-names></string-name>, <string-name name-style="western"><surname>Chan</surname><given-names>MTV</given-names></string-name>, <etal>et al.</etal></person-group><article-title>Implication of major adverse postoperative events and myocardial injury on disability and survival: a planned subanalysis of the ENIGMA-II Trial</article-title>. <source>Anesth Analg</source>. <year>2018</year>;<volume>127</volume>(<issue>5</issue>):<fpage>1118</fpage>&#8211;<lpage>1126</lpage>. doi: <pub-id pub-id-type="doi">10.1213/ANE.0000000000003310</pub-id>.<pub-id pub-id-type="pmid">29533264</pub-id></mixed-citation></ref><ref id="CIT0021"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mol</surname><given-names>KHJM</given-names></string-name>, <string-name name-style="western"><surname>van Lier</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Liem</surname><given-names>VGB</given-names></string-name>, <etal>et al.</etal></person-group><article-title>Immediate postoperative high-sensitivity troponin T concentrations and long-term patient-reported health-related quality of life: a prospective cohort study</article-title>. <source>Eur J Anaesthesiol</source>. <year>2020</year>;<volume>37</volume>(<issue>8</issue>):<fpage>680</fpage>&#8211;<lpage>687</lpage>. doi: <pub-id pub-id-type="doi">10.1097/EJA.0000000000001234</pub-id>.<pub-id pub-id-type="pmid">32618756</pub-id></mixed-citation></ref><ref id="CIT0022"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Vernooij</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>van Waes</surname><given-names>JAR</given-names></string-name>, <string-name name-style="western"><surname>Grobben</surname><given-names>RB</given-names></string-name>, <etal>et al.</etal></person-group><article-title>Postoperative myocardial injury phenotypes and self-reported disability in patients undergoing noncardiac surgery: a multicentre observational study</article-title>. <source>Br J Anaesth</source>. <year>2024</year>;<volume>132</volume>(<issue>1</issue>):<fpage>35</fpage>&#8211;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bja.2023.10.012</pub-id>.<pub-id pub-id-type="pmid">38057252</pub-id></mixed-citation></ref><ref id="CIT0023"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dong</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></string-name></person-group><article-title>The geography of healthcare: mapping patient flow and medical resource allocation in China</article-title>. <source>Econ Hum Biol</source>. <year>2024</year>;<volume>55</volume>:<fpage>101431</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ehb.2024.101431</pub-id>.<pub-id pub-id-type="pmid">39326297</pub-id></mixed-citation></ref><ref id="CIT0024"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gamliel</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Peer</surname><given-names>E.</given-names></string-name></person-group><article-title>Attribute framing affects the perceived fairness of health care allocation principles</article-title>. <source>Judgm Decis Mak</source>. <year>2010</year>;<volume>5</volume>(<issue>1</issue>):<fpage>11</fpage>&#8211;<lpage>20</lpage>. doi: <pub-id pub-id-type="doi">10.1017/S1930297500001996</pub-id>.</mixed-citation></ref><ref id="CIT0025"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Alvarez Torres</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Bartoszko</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Martinez Perez</surname><given-names>S</given-names></string-name>, <etal>et al.</etal></person-group><article-title>Effect of a national guideline on postoperative troponin surveillance: a retrospective cohort study</article-title>. <source>Can J Anaesth</source>. <year>2024</year>;<volume>71</volume>(<issue>3</issue>):<fpage>322</fpage>&#8211;<lpage>329</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12630-023-02647-4</pub-id>.<pub-id pub-id-type="pmid">37973786</pub-id></mixed-citation></ref><ref id="CIT0026"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Buse</surname><given-names>GL</given-names></string-name>, <string-name name-style="western"><surname>Matot</surname><given-names>I.</given-names></string-name></person-group><article-title>Pro-con debate: cardiac troponin measurement as part of routine follow-up of myocardial damage following noncardiac surgery</article-title>. <source>Anesth Analg</source>. <year>2022</year>;<volume>134</volume>(<issue>2</issue>):<fpage>257</fpage>&#8211;<lpage>265</lpage>. doi: <pub-id pub-id-type="doi">10.1213/ANE.0000000000005714</pub-id>.<pub-id pub-id-type="pmid">35030121</pub-id></mixed-citation></ref><ref id="CIT0027"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Buse</surname><given-names>GL</given-names></string-name>, <string-name name-style="western"><surname>Manns</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Lamy</surname><given-names>A</given-names></string-name>, <etal>et al.</etal></person-group><article-title>Troponin T monitoring to detect myocardial injury after noncardiac surgery: a cost-consequence analysis</article-title>. <source>Can J Surg</source>. <year>2018</year>;<volume>61</volume>(<issue>3</issue>):<fpage>185</fpage>&#8211;<lpage>194</lpage>. doi: <pub-id pub-id-type="doi">10.1503/cjs.010217</pub-id>.<pub-id pub-id-type="pmid">29806816</pub-id><pub-id pub-id-type="pmcid">PMC5973906</pub-id></mixed-citation></ref><ref id="CIT0028"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Armillotta</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Bergamaschi</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Paolisso</surname><given-names>P</given-names></string-name>, <etal>et al.</etal></person-group><article-title>Prognostic relevance of type 4A myocardial infarction and periprocedural myocardial injury in patients with non-ST-segment-elevation myocardial infarction</article-title>. <source>Circulation</source>. <year>2025</year>;<volume>151</volume>(<issue>11</issue>):<fpage>760</fpage>&#8211;<lpage>772</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.124.070729</pub-id>.<pub-id pub-id-type="pmid">39968630</pub-id><pub-id pub-id-type="pmcid">PMC11913249</pub-id></mixed-citation></ref></ref-list><glossary><def-list><title>Abbreviations</title><def-item><term>AKI</term><def><p>Acute kidney injury</p></def></def-item><def-item><term>BMI</term><def><p>Body mass index</p></def></def-item><def-item><term>eGFR</term><def><p>Estimated glomerular filtration rate</p></def></def-item></def-list></glossary></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>